10-Q: Quarterly report pursuant to Section 13 or 15(d)
Published on May 7, 2024
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form
For the quarterly period ended
Or
For the transition period from ____________ to____________
Commission File Number:
TTM TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
|
||
|
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
(Address of principal executive offices)
(
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading symbol(s) |
Name of each exchange on which registered |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
☑ |
Accelerated filer |
☐ |
|
Non-accelerated filer |
☐ |
Smaller reporting company |
|
|
|
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
As of May 2, 2024, there were outstanding
TTM TECHNOLOGIES, INC.
Form 10-Q
For the Quarter Ended April 1, 2024
TABLE OF CONTENTS
2
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (unaudited)
TTM TECHNOLOGIES, INC.
Consolidated Condensed Balance Sheets
As of April 1, 2024 and January 1, 2024
|
|
As of |
|
|||||
|
|
April 1, 2024 |
|
|
January 1, 2024 |
|
||
|
|
(Unaudited) |
|
|||||
|
|
(In thousands, except par value) |
|
|||||
ASSETS |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
|
|
$ |
|
||
Accounts receivable, net |
|
|
|
|
|
|
||
Contract assets |
|
|
|
|
|
|
||
Inventories |
|
|
|
|
|
|
||
Receivable from sale of Shanghai E-MS (SH E-MS) property |
|
|
|
|
|
|
||
Prepaid expenses and other current assets |
|
|
|
|
|
|
||
Total current assets |
|
|
|
|
|
|
||
Property, plant, and equipment, net |
|
|
|
|
|
|
||
Operating lease right-of-use assets |
|
|
|
|
|
|
||
Goodwill |
|
|
|
|
|
|
||
Definite-lived intangibles, net |
|
|
|
|
|
|
||
Deposits and other non-current assets |
|
|
|
|
|
|
||
Total assets |
|
$ |
|
|
$ |
|
||
|
|
|
|
|
|
|
||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Short-term debt, including current portion of long-term debt |
|
$ |
|
|
$ |
|
||
Accounts payable |
|
|
|
|
|
|
||
Contract liabilities |
|
|
|
|
|
|
||
Accrued salaries, wages, and benefits |
|
|
|
|
|
|
||
Other current liabilities |
|
|
|
|
|
|
||
Total current liabilities |
|
|
|
|
|
|
||
Long-term debt, net of discount and issuance costs |
|
|
|
|
|
|
||
Operating lease liabilities |
|
|
|
|
|
|
||
Other long-term liabilities |
|
|
|
|
|
|
||
Total long-term liabilities |
|
|
|
|
|
|
||
|
|
|
|
|
|
|||
Equity: |
|
|
|
|
|
|
||
Common stock, $ |
|
|
|
|
|
|
||
Treasury stock – common stock at cost; |
|
|
( |
) |
|
|
( |
) |
Additional paid-in capital |
|
|
|
|
|
|
||
Retained earnings |
|
|
|
|
|
|
||
Accumulated other comprehensive loss |
|
|
( |
) |
|
|
( |
) |
Total stockholders’ equity |
|
|
|
|
|
|
||
Total liabilities and stockholders' equity |
|
$ |
|
|
$ |
|
||
See accompanying notes to consolidated condensed financial statements.
3
TTM TECHNOLOGIES, INC.
Consolidated Condensed Statements of Operations
For the Quarters Ended April 1, 2024 and April 3, 2023
|
|
Quarter Ended |
|
|||||
|
|
April 1, 2024 |
|
|
April 3, 2023 |
|
||
|
|
(Unaudited) |
|
|||||
|
|
(In thousands, except per share data) |
|
|||||
Net sales |
|
$ |
|
|
$ |
|
||
Cost of goods sold |
|
|
|
|
|
|
||
Gross profit |
|
|
|
|
|
|
||
Operating expenses: |
|
|
|
|
|
|
||
Selling and marketing |
|
|
|
|
|
|
||
General and administrative |
|
|
|
|
|
|
||
Research and development |
|
|
|
|
|
|
||
Amortization of definite-lived intangibles |
|
|
|
|
|
|
||
Restructuring charges |
|
|
|
|
|
|
||
Total operating expenses |
|
|
|
|
|
|
||
Operating income (loss) |
|
|
|
|
|
( |
) |
|
Other (expense) income: |
|
|
|
|
|
|
||
Interest expense |
|
|
( |
) |
|
|
( |
) |
Gain on sale of subsidiary |
|
|
|
|
|
|
||
Other, net |
|
|
|
|
|
|
||
Total other expense, net |
|
|
( |
) |
|
|
( |
) |
Income (loss) before income taxes |
|
|
|
|
|
( |
) |
|
Income tax (provision) benefit |
|
|
( |
) |
|
|
|
|
Net income (loss) |
|
$ |
|
|
$ |
( |
) |
|
|
|
|
|
|
|
|
||
Earnings (loss) per share: |
|
|
|
|
|
|
||
Basic earnings (loss) per share |
|
$ |
|
|
$ |
( |
) |
|
Diluted earnings (loss) per share |
|
|
|
|
|
( |
) |
|
See accompanying notes to consolidated condensed financial statements.
4
TTM TECHNOLOGIES, INC.
Consolidated Condensed Statements of Comprehensive Income (Loss)
For the Quarters Ended April 1, 2024 and April 3, 2023
|
|
Quarter Ended |
|
|||||
|
|
April 1, 2024 |
|
|
April 3, 2023 |
|
||
|
|
(Unaudited) |
|
|||||
|
|
(In thousands) |
|
|||||
Net income (loss) |
|
$ |
|
|
$ |
( |
) |
|
Other comprehensive income (loss), net of tax: |
|
|
|
|
|
|
||
Pension obligation adjustments, net |
|
|
|
|
|
|
||
Foreign currency translation adjustments, net |
|
|
( |
) |
|
|
|
|
Derecognition of foreign currency translation adjustments |
|
|
|
|
|
( |
) |
|
Net unrealized gain (loss) on cash flow hedges: |
|
|
|
|
|
|
||
Unrealized gain (loss) on effective cash flow hedges during |
|
|
|
|
|
( |
) |
|
Amounts realized in the statement of operations, net |
|
|
( |
) |
|
|
|
|
Net |
|
|
|
|
|
( |
) |
|
Other comprehensive income (loss), net of tax |
|
|
|
|
|
( |
) |
|
Comprehensive income (loss), net of tax |
|
$ |
|
|
$ |
( |
) |
|
See accompanying notes to consolidated condensed financial statements.
5
TTM TECHNOLOGIES, INC.
Consolidated Condensed Statements of Stockholders’ Equity
For the Quarters Ended April 1, 2024 and April 3, 2023
|
|
Common Stock |
|
|
Treasury Stock |
|
|
Additional |
|
|
Retained |
|
|
Accumulated |
|
|
Total |
|
||||||||||||||
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Earnings |
|
|
Loss |
|
|
Equity |
|
||||||||
|
|
(Unaudited) |
|
|||||||||||||||||||||||||||||
|
|
(In thousands) |
|
|||||||||||||||||||||||||||||
Balance, January 1, 2024 |
|
|
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Other comprehensive income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
||
Issuance of common stock for |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
||
Issuance of common stock for |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Repurchases of common stock |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Balance, April 1, 2024 |
|
|
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
|
|
Common Stock |
|
|
Treasury Stock |
|
|
Additional |
|
|
Retained |
|
|
Accumulated |
|
|
Total |
|
||||||||||||||
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Earnings |
|
|
Loss |
|
|
Equity |
|
||||||||
|
|
(Unaudited) |
|
|||||||||||||||||||||||||||||
|
|
(In thousands) |
|
|||||||||||||||||||||||||||||
Balance, January 2, 2023 |
|
|
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Other comprehensive loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Issuance of common stock for |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Issuance of common stock for |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Balance, April 3, 2023 |
|
|
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
See accompanying notes to consolidated condensed financial statements.
6
TTM TECHNOLOGIES, INC.
Consolidated Condensed Statements of Cash Flows
For the Quarters Ended April 1, 2024 and April 3, 2023
|
|
Quarter Ended |
|
|||||
|
|
April 1, 2024 |
|
|
April 3, 2023 |
|
||
|
|
(Unaudited) |
|
|||||
|
|
(In thousands) |
|
|||||
Cash flows from operating activities: |
|
|
|
|
|
|
||
Net income (loss) |
|
$ |
|
|
$ |
( |
) |
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
|
|
|
||
Depreciation of property, plant, and equipment |
|
|
|
|
|
|
||
Amortization of definite-lived intangible assets |
|
|
|
|
|
|
||
Amortization of debt discount and issuance costs |
|
|
|
|
|
|
||
Deferred income taxes |
|
|
|
|
|
( |
) |
|
Stock-based compensation |
|
|
|
|
|
|
||
Gain on sale of subsidiary |
|
|
|
|
|
( |
) |
|
Other |
|
|
( |
) |
|
|
( |
) |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
||
Accounts receivable, net |
|
|
|
|
|
|
||
Contract assets |
|
|
( |
) |
|
|
|
|
Inventories |
|
|
( |
) |
|
|
( |
) |
Prepaid expenses and other current assets |
|
|
( |
) |
|
|
|
|
Accounts payable |
|
|
|
|
|
( |
) |
|
Contract liabilities |
|
|
( |
) |
|
|
|
|
Accrued salaries, wages, and benefits |
|
|
( |
) |
|
|
( |
) |
Other current liabilities |
|
|
( |
) |
|
|
( |
) |
Net cash provided by operating activities |
|
|
|
|
|
|
||
Cash flows from investing activities: |
|
|
|
|
|
|
||
Proceeds from sale of SH E-MS property |
|
|
|
|
|
|
||
Purchase of property, plant, and equipment and other assets |
|
|
( |
) |
|
|
( |
) |
Proceeds from sale of property, plant, and equipment and other assets |
|
|
|
|
|
|
||
Proceeds from sale of subsidiary, net of cash disposed |
|
|
|
|
|
|
||
Net cash (used in) provided by investing activities |
|
|
( |
) |
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
||
Repayment of long-term debt borrowing |
|
|
( |
) |
|
|
( |
) |
Repurchases of common stock |
|
|
( |
) |
|
|
|
|
Net cash used in financing activities |
|
|
( |
) |
|
|
( |
) |
Effect of foreign currency exchange rates on cash and cash equivalents |
|
|
( |
) |
|
|
( |
) |
Net (decrease) increase in cash and cash equivalents |
|
|
( |
) |
|
|
|
|
Cash and cash equivalents at beginning of period |
|
|
|
|
|
|
||
Cash and cash equivalents at end of period |
|
$ |
|
|
$ |
|
||
Supplemental cash flow information: |
|
|
|
|
|
|
||
Cash paid, net for interest |
|
$ |
|
|
$ |
|
||
Cash paid, net for income taxes |
|
|
|
|
|
|
||
Supplemental disclosure of noncash investing activities: |
|
|
|
|
|
|
||
Property, plant, and equipment recorded in accounts payable and other current liabilities |
|
$ |
|
|
$ |
|
||
See accompanying notes to consolidated condensed financial statements.
7
TTM TECHNOLOGIES, INC.
Notes to Consolidated Condensed Financial Statements
(Unaudited)
(Dollars and shares in thousands, except per share data)
(1) Nature of Operations and Basis of Presentation
TTM Technologies, Inc. (the Company or TTM) is a leading global manufacturer of technology solutions including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, and quick-turn and technologically advanced printed circuit boards (PCB). The Company provides time-to-market and volume production of advanced technology products and offers a one-stop design, engineering, and manufacturing solution to customers. This solution allows the Company to align technology developments with the diverse needs of the Company’s customers and to enable them to reduce the time required to develop new products and bring them to market.
The Company serves a diversified customer base in various markets throughout the world, including aerospace and defense, data center computing, automotive, medical, industrial and instrumentation related products, and networking. The Company’s customers include original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, original design manufacturers (ODMs), distributors, and government agencies (both domestic and allied foreign governments).
The accompanying consolidated condensed financial statements have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. These consolidated condensed financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s most recent Annual Report on Form 10-K. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s consolidated condensed financial statements and accompanying notes. Due, in part, to the conflict between Russia and Ukraine, and the conflict in Israel and the Gaza Strip, the global economy and financial markets have been volatile. The Company has considered information available to it as of the date of issuance of these financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgments, or a revision to the carrying value of its assets or liabilities. The actual results the Company experienced may differ materially and adversely from its estimates. The Company uses a 52/53 week fiscal calendar with the fourth quarter ending on the Monday nearest December 31.
Recently Issued Accounting Standards Not Yet Adopted
In March 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2024-02, Codification Improvements - Amendments to Remove References to the Concepts Statements, to remove various references to concepts statements from the Accounting Standards Codification (ASC). These amendments clarify guidance, simplify wording or structure of guidance, and other minor improvements. The amendments are effective for fiscal years beginning after December 15, 2024, applied prospectively, with early adoption and retrospective application permitted. The impact of the adoption of the amendments in this update is not expected to be material to the Company's consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The update will be effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements not yet issued or made available for issuance. The Company is currently evaluating the new guidance to determine the impact it may have on its consolidated financial statements and related disclosures, but expects additional disclosures upon adoption.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the new guidance to determine the impact it may have on its consolidated financial statements and related disclosures, but expects additional disclosures upon adoption.
8
In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the Securities and Exchange Commission’s Disclosure Update and Simplification Initiative, which modifies the disclosure or presentation requirements of a variety of topics in the ASC in response to the SEC’s Release No. 33-10532, Disclosure Update and Simplification Initiative, and align the ASC requirements with the SEC’s regulations. For entities subject to the SEC's existing disclosure requirements, the effective date for each amendment will be the date on which the SEC's removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective. However, if by June 30, 2027, the SEC has not removed the related disclosure from its regulations, the amendments will be removed from the Codification and not become effective. Early adoption is prohibited. The Company is currently evaluating the new guidance to determine the impact it may have on its consolidated financial statements and related disclosures.
(2) Share Repurchase Program
On May 3, 2023, the Company's Board of Directors authorized and approved a share repurchase program (2023 Repurchase Program), under which the Company may repurchase up to $
During the quarter ended April 1, 2024, the Company repurchased
(3) Significant Customers and Concentration of Credit Risk
Financial instruments that are potentially subject to concentrations of credit risk are primarily cash and cash equivalents and accounts receivable.
The Company had cash and cash equivalents held by its foreign subsidiaries of $
In the normal course of business, the Company extends credit to its customers. Some customers to whom the Company extends credit are located outside the United States. The Company performs on-going credit evaluations of customers, does not require collateral, and considers the credit risk profile of the entity from which the receivable is due in further evaluating collection risk. As of April 1, 2024, there was
The Company’s customers include both OEMs and EMS companies. The Company’s OEM customers often direct a significant portion of their purchases through EMS companies. While the Company’s customers include both OEM and EMS providers, the Company measures customer concentration based on OEM companies, as they are the ultimate end customers.
For the quarter ended April 1, 2024,
9
(4) Revenues
As of April 1, 2024, the aggregate amount of the transaction price allocated to remaining performance obligations for long-term contracts was $
For contracts in which anticipated total costs exceed the total expected revenue, an estimated loss is recognized in the period when identifiable. A provision for the entire amount of the estimated loss is recorded on a cumulative basis. The estimated remaining costs to complete for loss contracts as of April 1, 2024 and January 1, 2024 were $
Revenue recognized for the quarter ended April 1, 2024 from amounts recorded as contract liabilities as of January 1, 2024 was $
Revenue from products and services transferred to customers over time and at a point in time accounted for
Disaggregated revenue by principal end markets with reportable segments was as follows:
|
|
Quarter Ended April 1, 2024 |
|
|||||||||
|
|
PCB |
|
|
RF and Specialty Components |
|
|
Total |
|
|||
|
|
(In thousands) |
|
|||||||||
End Markets: |
|
|
|
|
|
|
|
|
|
|||
Aerospace and Defense |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Automotive |
|
|
|
|
|
|
|
|
|
|||
Data Center Computing |
|
|
|
|
|
|
|
|
|
|||
Medical/Industrial/Instrumentation |
|
|
|
|
|
|
|
|
|
|||
Networking |
|
|
|
|
|
|
|
|
|
|||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
Quarter Ended April 3, 2023 |
|
|||||||||
|
|
PCB |
|
|
RF&S Components |
|
|
Total |
|
|||
|
|
(In thousands) |
|
|||||||||
End Markets: |
|
|
|
|
|
|
|
|
|
|||
Aerospace and Defense |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Automotive |
|
|
|
|
|
|
|
|
|
|||
Data Center Computing |
|
|
|
|
|
|
|
|
|
|||
Medical/Industrial/Instrumentation |
|
|
|
|
|
|
|
|
|
|||
Networking |
|
|
|
|
|
|
|
|
|
|||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|||
10
(5) Composition of Certain Consolidated Condensed Financial Statement Captions
|
|
As of |
|
|||||
|
|
April 1, 2024 |
|
|
January 1, 2024 |
|
||
|
|
(In thousands) |
|
|||||
Inventories: |
|
|
|
|
|
|
||
Raw materials |
|
$ |
|
|
$ |
|
||
Work-in-process |
|
|
|
|
|
|
||
Finished goods |
|
|
|
|
|
|
||
Inventories |
|
$ |
|
|
$ |
|
||
|
|
|
|
|
|
|
||
Property, plant, and equipment, net: |
|
|
|
|
|
|
||
Land and land use rights |
|
$ |
|
|
$ |
|
||
Buildings and improvements |
|
|
|
|
|
|
||
Machinery and equipment |
|
|
|
|
|
|
||
Furniture and fixtures and other |
|
|
|
|
|
|
||
Construction-in-progress |
|
|
|
|
|
|
||
Property, plant, and equipment, gross |
|
|
|
|
|
|
||
Less: Accumulated depreciation |
|
|
( |
) |
|
|
( |
) |
Property, plant, and equipment, net |
|
$ |
|
|
$ |
|
||
|
|
|
|
|
|
|
||
Other current liabilities: |
|
|
|
|
|
|
||
Accrued capital expenditures |
|
$ |
|
|
$ |
|
||
Sales return and allowances |
|
|
|
|
|
|
||
Accrued facility operating costs |
|
|
|
|
|
|
||
Operating leases |
|
|
|
|
|
|
||
Warranty |
|
|
|
|
|
|
||
Housing fund |
|
|
|
|
|
|
||
Income taxes payable |
|
|
|
|
|
|
||
Accrued professional fees |
|
|
|
|
|
|
||
Interest |
|
|
|
|
|
|
||
Restructuring |
|
|
|
|
|
|
||
Derivative liabilities |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
Other current liabilities |
|
$ |
|
|
$ |
|
||
|
|
|
|
|
|
|
||
Other long-term liabilities: |
|
|
|
|
|
|
||
Deferred income taxes |
|
$ |
|
|
$ |
|
||
Customer deposits |
|
|
|
|
|
|
||
Finance leases |
|
|
|
|
|
|
||
Defined benefit pension plan liability |
|
|
|
|
|
|
||
Derivative liabilities |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
Other long-term liabilities |
|
$ |
|
|
$ |
|
||
11
(6) Goodwill
Goodwill by reportable segment was as follows:
|
|
PCB |
|
|
RF&S Components |
|
|
Total |
|
|||
|
|
(In thousands) |
|
|||||||||
As of April 1, 2024 and January 1, 2024 |
|
|
|
|
|
|
|
|
|
|||
Goodwill |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Accumulated impairment losses |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Carrying amount |
|
$ |
|
|
$ |
|
|
$ |
|
|||
(7) Definite-lived Intangibles
The components of definite-lived intangibles were as follows:
|
|
Gross |
|
|
Accumulated |
|
|
Net |
|
|
Weighted |
|
||||
|
|
(In thousands) |
|
|
(In years) |
|
||||||||||
As of April 1, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Customer relationships |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
|
|
|||
Technology |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|||
Backlog |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|||
Trade names |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|||
Total |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
As of January 1, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Customer relationships |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
|
|
|||
Technology |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|||
Backlog |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|||
Trade names |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|||
Total |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
|
|
|||
Definite-lived intangibles are amortized using the straight-line method of amortization over the useful life. Amortization expense was $
Estimated aggregate amortization for definite-lived intangible assets for the next five years and thereafter is as follows:
|
|
(In thousands) |
|
|
Remaining 2024 |
|
$ |
|
|
2025 |
|
|
|
|
2026 |
|
|
|
|
2027 |
|
|
|
|
2028 |
|
|
|
|
Thereafter |
|
|
|
|
Total |
|
$ |
|
|
12
(8) Long-term Debt and Letters of Credit
Long-term debt was as follows:
|
|
As of April 1, 2024 |
|
|
As of January 1, 2024 |
|
||||||||||||
|
|
Interest Rate |
|
Principal |
|
|
Interest Rate |
|
Principal |
|
||||||||
|
|
(In thousands, except interest rates) |
|
|||||||||||||||
Senior Notes due |
|
|
|
% |
|
$ |
|
|
|
|
% |
|
$ |
|
||||
Term Loan due |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Asia ABL Revolving Loan due |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Less: Unamortized debt issuance costs |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
( |
) |
||
Less: Unamortized debt discount |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
( |
) |
||
Subtotal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Less: current maturities |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
( |
) |
||
Long-term debt, less current maturities |
|
|
|
|
|
$ |
|
|
|
|
|
|
$ |
|
||||
Debt Covenants
Borrowings under the Senior Notes due March 2029 and Term Loan due May 2030 (Term Loan Facility) are subject to certain affirmative and negative covenants, including limitations on indebtedness, corporate transactions, investments, dispositions, and restricted payments.
Under the occurrence of certain events, the U.S. Asset-Based Lending Credit Agreement (U.S. ABL) and Asia Asset-Based Lending Credit Agreement (Asia ABL) (collectively, the ABL Revolving Loans), are subject to various financial covenants, including leverage and fixed charge coverage ratios.
Debt Issuance Costs and Debt Discount
Remaining unamortized debt issuance costs and debt discount were as follows:
|
|
As of April 1, 2024 |
|
As of January 1, 2024 |
||||||||||||||||||||||
|
|
Debt |
|
|
Debt |
|
|
Effective |
|
Debt |
|
|
Debt |
|
|
Effective |
||||||||||
|
|
(In thousands, except interest rates) |
||||||||||||||||||||||||
Senior Notes due March 2029 |
|
$ |
|
|
$ |
— |
|
|
|
|
% |
|
$ |
|
|
$ |
— |
|
|
|
|
% |
||||
Term Loan due May 2030 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total |
|
$ |
|
|
$ |
|
|
|
|
|
|
$ |
|
|
$ |
|
|
|
|
|
||||||
The above debt issuance costs and debt discount are recorded as a reduction of the debt and are amortized into interest expense using an effective interest rate over the duration of the debt.
The remaining unamortized debt issuance costs for the ABL Revolving Loans of $
As of April 1, 2024, the remaining weighted average amortization period for all unamortized debt issuance costs and debt discount was
(9) Income Taxes
The Company’s effective tax rate is impacted by the mix of foreign and U.S. income, tax rates in China and Hong Kong, the U.S. federal income tax rate, apportioned state income tax rates, the generation of credits, and deductions available to the Company as well as changes in valuation allowances and certain non-deductible items. No tax benefit was recorded on the losses incurred in certain foreign jurisdictions as a result of corresponding increases in the valuation allowances in these jurisdictions.
During the quarter ended April 1, 2024, the Company’s effective tax rate was impacted by a net discrete expense of $
The Company has various foreign subsidiaries formed or acquired to conduct or support its business outside the U.S. The Company expects its earnings attributable to most foreign subsidiaries may be repatriated back to the U.S. and so a deferred tax liability has been recorded for foreign withholding taxes and the estimated federal/state tax impact on any repatriation. For those other companies with earnings currently being reinvested outside of the U.S., no deferred tax liability on undistributed earnings has been recorded.
13
(10) Segment Information
The Company’s reportable segments are the segments for which separate financial information is available and upon which operating results are evaluated by the chief operating decision maker to assess performance and to allocate resources.
The Company, including the chief operating decision maker, evaluates segment performance based on reportable segment income, which is operating income before amortization of intangibles. Interest expense and interest income are not presented by segment since they are not included in the measure of segment profitability reviewed by the chief operating decision maker. All inter-segment transactions have been eliminated.
|
|
Quarter Ended |
|
|||||
|
|
April 1, 2024 |
|
|
April 3, 2023 |
|
||
|
|
(In thousands) |
|
|||||
Net Sales: |
|
|
|
|
|
|
||
PCB |
|
$ |
|
|
$ |
|
||
RF&S Components |
|
|
|
|
|
|
||
Total net sales |
|
$ |
|
|
$ |
|
||
Operating Segment Income: |
|
|
|
|
|
|
||
PCB |
|
$ |
|
|
$ |
|
||
RF&S Components |
|
|
|
|
|
|
||
Corporate and Other |
|
|
( |
) |
|
|
( |
) |
Total operating segment income |
|
|
|
|
|
|
||
Amortization of definite-lived intangibles (1) |
|
|
( |
) |
|
|
( |
) |
Total operating income (loss) |
|
|
|
|
|
( |
) |
|
Total other expense |
|
|
( |
) |
|
|
( |
) |
Income (loss) before income taxes |
|
$ |
|
|
$ |
( |
) |
|
|
|
As of |
|
|||||
|
|
April 1, 2024 |
|
|
January 1, 2024 |
|
||
|
|
(In thousands) |
|
|||||
Segment Assets: |
|
|
|
|
|
|
||
PCB |
|
$ |
|
|
$ |
|
||
RF&S Components |
|
|
|
|
|
|
||
Corporate and Other |
|
|
|
|
|
|
||
Total assets |
|
$ |
|
|
$ |
|
||
The Corporate and Other category primarily includes operating expenses that are not included in the segment operating performance measures. Corporate and Other consists primarily of corporate governance functions such as finance, accounting, information technology, and human resources personnel, as well as global sales and marketing personnel, research and development costs, and acquisition and integration costs associated with acquisitions and divestitures.
The Company markets and sells its products in approximately
|
|
Quarter Ended |
|
|||||
|
|
April 1, 2024 |
|
|
April 3, 2023 |
|
||
|
|
(In thousands) |
|
|||||
Net Sales: |
|
|
|
|
|
|
||
United States |
|
$ |
|
|
$ |
|
||
Taiwan |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
Total net sales |
|
$ |
|
|
$ |
|
||
14
(11) Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss, net of tax, were as follows:
|
|
Foreign |
|
|
Pension |
|
|
Gains (Losses) |
|
|
Total |
|
||||
|
|
(In thousands) |
|
|||||||||||||
Ending balance as of January 1, 2024 |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
||
Other comprehensive (loss) income |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|||
Amounts reclassified from accumulated |
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
||
Net year to date other comprehensive (loss) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|||
Ending balance as of April 1, 2024 |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
||
(12) Financial Instruments
Derivatives
Interest Rate Swaps
The Company’s business is exposed to risk resulting from fluctuations in interest rates on certain Secured Overnight Financing Rate (SOFR) based variable rate debt. Increases in interest rates increase interest expenses relating to the outstanding variable rate borrowings and increase the cost of debt. Fluctuations in interest rates can also lead to significant fluctuations in the fair value of the debt obligations.
On March 23, 2023, the Company entered into a
At inception, the Company designated the interest rate swap as a cash flow hedge and the fair value of the interest rate swap was
Foreign Exchange Contracts
The Company’s foreign subsidiaries may at times enter into forward exchange contracts to manage their foreign currency risks in relation to certain purchases of equipment denominated in foreign currencies other than the Company’s functional currencies. The notional amount of the foreign exchange contracts was $
Commodity Price Risk Management
The Company uses various raw materials in the manufacturing of PCBs. Copper clad laminates (CCLs), a key raw material for the manufacture of PCBs, are made from epoxy resin, glass cloth, and copper foil. The Company only buys a small amount of copper directly. However, copper is a major driver of laminate cost. The Company enters into commodity contracts to hedge copper as a proxy for hedging laminate. As of April 1, 2024, the Company has commodity contracts with a notional quantity of (i)
15
The fair values of derivative instruments in the consolidated condensed balance sheets were as follows:
|
|
|
|
Asset/(Liability) Fair Value |
|
|||||
|
|
Balance Sheet Location |
|
April 1, 2024 |
|
|
January 1, 2024 |
|
||
|
|
|
|
(In thousands) |
|
|||||
Cash flow derivative instruments designated as hedges: |
|
|
|
|
|
|
||||
Interest rate swap |
|
Prepaid expenses and other current assets |
|
$ |
|
|
$ |
|
||
Foreign exchange contracts |
|
Prepaid expenses and other current assets |
|
|
|
|
|
|
||
Interest rate swap |
|
Deposits and other non-current assets |
|
|
|
|
|
|
||
Foreign exchange contracts |
|
Other current liabilities |
|
|
( |
) |
|
|
|
|
Interest rate swap |
|
Other long-term liabilities |
|
|
|
|
|
( |
) |
|
Cash flow derivative instruments not designated as hedges: |
|
|
|
|
|
|
||||
Commodity contracts |
|
Prepaid expenses and other current assets |
|
$ |
|
|
$ |
|
||
Commodity contracts |
|
Other current liabilities |
|
|
|
|
|
( |
) |
|
Amounts recorded in accumulated other comprehensive loss related to derivatives designated as cash flow hedges, as well as the amounts recorded in each caption in the consolidated condensed statements of operations when derivative amounts are reclassified out of accumulated other comprehensive loss were as follows:
|
|
|
|
Quarter Ended April 1, 2024 |
|
|
Quarter Ended April 3, 2023 |
|
||||||||||
|
|
Financial |
|
Gain Recognized in Other Comprehensive Loss |
|
|
Amounts |
|
|
Loss Recognized |
|
|
Amounts |
|
||||
|
|
|
|
(In thousands) |
|
|||||||||||||
Cash flow hedge: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Interest rate swap |
|
Interest expense |
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
||
The activity associated with the designated cash flow hedges reflected in accumulated other comprehensive loss was as follows:
|
|
Quarter Ended |
|
|||||
|
|
April 1, 2024 |
|
|
April 3, 2023 |
|
||
|
|
(In thousands) |
|
|||||
Beginning balance, net of tax |
|
$ |
|
|
$ |
( |
) |
|
Changes in fair value gain (loss), net of tax |
|
|
|
|
|
( |
) |
|
Reclassification to earnings |
|
|
( |
) |
|
|
|
|
Ending balance, net of tax |
|
$ |
|
|
$ |
( |
) |
|
(13) Fair Value Measures
The Company measures at fair value its financial and non-financial assets by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability.
The carrying amount and estimated fair value of the Company’s financial instruments were as follows:
|
|
As of April 1, 2024 |
|
|
As of January 1, 2024 |
|
||||||||||
|
|
Carrying |
|
|
Fair Value |
|
|
Carrying |
|
|
Fair Value |
|
||||
|
|
(In thousands) |
|
|||||||||||||
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Derivative assets, non-current |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Derivative liabilities, current |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Derivative liabilities, non-current |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Senior Notes due March 2029 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Term Loan due May 2030 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
ABL Revolving Loans |
|
|
|
|
|
|
|
|
|
|
|
|
||||
The fair value of the derivative instruments was determined using pricing models developed based on the 1-month CME Term SOFR swap rate, foreign currency exchange rates, and other observable market data, including quoted market prices, as appropriate using Level 2 inputs. The values were adjusted to reflect non-performance risk of both the counterparty and the Company, as necessary.
16
The fair value of the long-term debt was estimated based on quoted market prices or discounting the debt over its life using current market rates for similar debt as of April 1, 2024 and January 1, 2024, which are considered Level 2 inputs.
As of April 1, 2024 and January 1, 2024, the Company’s other financial instruments included cash and cash equivalents, accounts receivable, contract assets, accounts payable, and contract liabilities. The carrying amount of these instruments approximates fair value.
The majority of the Company’s non-financial assets and liabilities, which include goodwill, intangible assets, inventories, and property, plant, and equipment, are not required to be carried at fair value on a recurring basis. However, if certain triggering events occur (or are tested at least annually in the case of goodwill) such that a non-financial instrument is required to be evaluated for impairment, based upon a comparison of the non-financial instrument’s fair value to its carrying value, an impairment is recorded to reduce the carrying value to the fair value, if the carrying value exceeds the fair value.
(14) Commitments and Contingencies
Legal Matters
The Company is subject to various legal matters, which it considers normal for its business activities. While the Company currently believes that the amount of any reasonably possible loss for known matters would not be material to the Company’s financial condition, the outcome of these actions is inherently difficult to predict. In the event of an adverse outcome, the ultimate potential loss could have a material adverse effect on the Company’s financial condition or results of operations in a particular period. The Company has accrued amounts for its loss contingencies which are probable and estimable as of April 1, 2024 and January 1, 2024 and included as a component of other current liabilities. However, these amounts are not material to the consolidated condensed financial statements of the Company.
Offset Agreements
The Company has and may continue to enter into industrial cooperation agreements, sometimes referred to as offset agreements, as a condition to obtaining orders for products and services from customers in foreign countries. These agreements are intended to promote investment in the applicable country, and the Company’s obligations under these agreements may be satisfied through activities that do not require the Company to use cash, including transferring technology or providing manufacturing and other consulting support. The obligations under these agreements may also be satisfied through the use of cash for activities such as purchasing supplies from in-country vendors, setting up support centers, research and development investments, acquisitions, and building or leasing facilities for in-country operations. The amount of the offset requirement is determined by contract value awarded and negotiated percentages with customers. As of April 1, 2024, the Company had outstanding offset agreements of approximately $
Supplier Finance Program Obligations
The Company has agreements with financial institutions to facilitate payments to certain suppliers. Under the terms of the agreements, the Company confirms the validity of each supplier invoice to the respective financial institution upon receipt. The supplier receives payment from the financial institution, and the Company pays the financial institution based on the terms negotiated, which generally range from
(15) Earnings (Loss) Per Share
The reconciliation of the numerator and denominator used to calculate basic earnings (loss) per share and diluted earnings (loss) per share is as follows:
|
|
Quarter Ended |
|
|||||
|
|
April 1, 2024 |
|
|
April 3, 2023 |
|
||
|
|
(In thousands, except per share amounts) |
|
|||||
Net income (loss) |
|
$ |
|
|
$ |
( |
) |
|
|
|
|
|
|
|
|
||
Basic weighted average shares |
|
|
|
|
|
|
||
Dilutive effect of performance-based restricted stock |
|
|
|
|
|
|
||
Diluted shares |
|
|
|
|
|
|
||
Earnings (loss) per share: |
|
|
|
|
|
|
||
Basic |
|
$ |
|
|
$ |
( |
) |
|
Diluted |
|
$ |
|
|
$ |
( |
) |
|
17
Restricted stock units (RSUs) and stock options to purchase
For the quarter ended April 3, 2023, potential shares of common stock, consisting of stock options to purchase approximately
(16) Stock-Based Compensation
Performance-based Restricted Stock Units
The Company maintains a long-term incentive program for executives that provides for the issuance of PRUs, representing hypothetical shares of the Company’s common stock that may be issued. Under the PRU program, a target number of PRUs is awarded at the beginning of each
Under the PRU program, financial goals with respect to one or more target milestones are set at the beginning of each fiscal year and performance is reviewed at the end of that year. The percentage to be applied to each participant’s target award ranges from
At the end of the three-year performance period, the total units earned, if any, are adjusted by adding the TSR calculation. The TSR calculation is a percentage ranging from
Stock-based Compensation Expense and Unrecognized Compensation Costs
Stock-based compensation expense recognized in the accompanying consolidated condensed statements of operations was as follows:
|
|
Quarter Ended |
|
|||||
|
|
April 1, 2024 |
|
|
April 3, 2023 |
|
||
|
|
(In thousands) |
|
|||||
Cost of goods sold |
|
$ |
|
|
$ |
|
||
Selling and marketing |
|
|
|
|
|
|
||
General and administrative |
|
|
|
|
|
|
||
Research and development |
|
|
|
|
|
|
||
Stock-based compensation expense recognized |
|
$ |
|
|
$ |
|
||
A summary of total unrecognized compensation costs as of April 1, 2024 was as follows:
|
|
Unrecognized Compensation Costs |
|
|
Remaining Weighted Average |
|
||
|
|
(In thousands) |
|
|
(In years) |
|
||
RSU awards |
|
$ |
|
|
|
|
||
PRU awards |
|
|
|
|
|
|
||
Total |
|
$ |
|
|
|
|
||
18
(17) Restructuring Charges
On February 8, 2023, the Company announced a consolidation plan, pursuant to which the Company ceased operations at
In addition to this consolidation plan, the Company recognized employee separation, contract termination, and other costs during the quarters ended April 1, 2024 and April 3, 2023 in connection with other global realignment restructuring efforts. Contract termination and other costs primarily represented plant closure costs.
Restructuring costs by reportable segment were as follows:
|
|
Quarter Ended April 1, 2024 |
|
|||||||||
|
|
Employee |
|
|
Contract |
|
|
Total |
|
|||
|
|
(In thousands) |
|
|||||||||
Reportable Segment: |
|
|
|
|
|
|
|
|
|
|||
PCB |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Corporate and Other |
|
|
|
|
|
|
|
|
|
|||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
Quarter Ended April 3, 2023 |
|
|||||||||
|
|
Employee |
|
|
Contract |
|
|
Total |
|
|||
|
|
(In thousands) |
|
|||||||||
Reportable Segment: |
|
|
|
|
|
|
|
|
|
|||
PCB |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Corporate and Other |
|
|
|
|
|
|
|
|
|
|||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Accrued restructuring costs are included as a component of other current liabilities in the consolidated condensed balance sheet. The utilization of the accrued restructuring costs was as follows:
|
|
Employee |
|
|
Contract |
|
|
Total |
|
|||
|
|
(In thousands) |
|
|||||||||
Accrued as of January 1, 2024 |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Charged to expense |
|
|
|
|
|
|
|
|
|
|||
Amount paid |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Accrued as of April 1, 2024 |
|
$ |
|
|
$ |
|
|
$ |
|
|||
19
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Cautionary Statement Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q (Report) contains forward-looking statements regarding future events or our future financial and operational performance. Forward-looking statements include statements regarding markets for our products; trends in net sales, gross profits, and estimated expense levels; liquidity and anticipated cash needs and availability; and any statement that contains the words “anticipate,” “believe,” “plan,” “forecast,” “foresee,” “estimate,” “project,” “expect,” “seek,” “target,” “intend,” “goal,” and other similar expressions. The forward-looking statements included in this report reflect our current expectations and beliefs, and we do not undertake publicly to update or revise these statements, even if experience or future changes make it clear that any projected results expressed in this report or future quarterly reports to stockholders, press releases, or company statements will not be realized. In addition, the inclusion of any statement in this report does not constitute an admission by us that the events or circumstances described in such statement are material. Furthermore, we wish to caution and advise readers that these statements are based on assumptions that may not materialize and may involve risks and uncertainties, many of which are beyond our control, that could cause actual events or performance to differ materially from those contained or implied in these forward-looking statements. These risks and uncertainties include the risks identified under the heading "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended January 1, 2024, as updated by our other filings with the Securities and Exchange Commission (SEC), and described elsewhere in this Report. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated condensed financial statements and the related notes and the other financial information included in this Report, as well as the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” set forth in our Annual Report on Form 10-K for the fiscal year ended January 1, 2024, filed with the SEC.
COMPANY OVERVIEW
We are a leading global manufacturer of technology solutions including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, and quick-turn and technologically advanced printed circuit boards (PCB). We focus on providing time-to-market and volume production of advanced technology products and offer a one-stop design, engineering, and manufacturing solution to our customers. This solution allows us to align technology development with the diverse needs of our customers and to enable them to reduce the time required to develop new products and bring them to market. We serve a diversified customer base consisting of approximately 1,500 customers in various markets throughout the world, including aerospace and defense, data center computing, automotive, medical, industrial and instrumentation, and networking. Our customers include original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, original design manufacturers (ODMs), distributors, and government agencies (both domestic and allied foreign governments).
RECENT DEVELOPMENTS
On November 1, 2023, we announced our selection of Syracuse, New York as the location for a new proposed advanced technology PCB manufacturing facility. We expect that the proposed facility will bring advanced technology capability for our domestic high-volume production of ultra-high-density interconnect (HDI) PCBs in support of national security requirements. We believe the planned investment aligns with New York State’s continuing focus on the region as a premier technology hub for U.S. electronics and the recent selection of Buffalo-Rochester-Syracuse (BRS) for the Federal Tech Hub designation. The project reflects our support for cultivating a stronger microelectronics ecosystem in New York and across the U.S. Aerospace and Defense industrial base. We are in the advanced stages of project planning, having identified the 24-acre property adjacent to our existing facility in Syracuse for the campus expansion and the site for the new facility. We have completed initial building designs and site layout, and are now applying for the required permitting. Groundbreaking is anticipated in the first half of 2024, with the project's final scale, scope, and timeline subject to finalizing funding with various stakeholders. Phase one of the proposed project, including capital for campus-wide improvements is estimated to be $100.0 million to $130.0 million, and is anticipated to run through 2026. Our planned capital investment commitments will be determined after finalizing terms with various stakeholders.
20
FINANCIAL OVERVIEW
While our customers include both OEMs and EMS providers, we measure customers based on OEM companies, as they are the ultimate end customers. Sales to our ten largest customers collectively accounted for 53% and 48% of our net sales for the quarters ended April 1, 2024 and April 3, 2023, respectively. We sell to OEMs both directly and indirectly through EMS providers.
The percentage of our net sales attributable to each of the principal end markets we served was as follows:
|
|
Quarter Ended |
||||||||
|
|
April 1, 2024 |
|
April 3, 2023 |
||||||
End Markets (1): |
|
|
|
|
|
|
|
|
||
Aerospace and Defense |
|
|
46 |
|
% |
|
|
43 |
|
% |
Automotive |
|
|
13 |
|
|
|
|
17 |
|
|
Data Center Computing |
|
|
21 |
|
|
|
|
10 |
|
|
Medical/Industrial/Instrumentation |
|
|
14 |
|
|
|
|
19 |
|
|
Networking |
|
|
6 |
|
|
|
|
11 |
|
|
Total |
|
|
100 |
|
% |
|
|
100 |
|
% |
We derive revenues primarily from the sale of PCBs, engineered systems using customer-supplied engineering and design plans as well as our long-term contracts related to the design and manufacture of highly sophisticated intelligence, surveillance, and communications solutions, and RF and microwave/microelectronics components, assemblies, and subsystems. Orders for products generally correspond to the production schedules of our customers and are supported with firm purchase orders. Our customers have continuous control of the work in progress and finished goods throughout the PCB and engineered systems manufacturing process, as these are built to customer specifications with no alternative use, and there is an enforceable right of payment for work performed to date. As a result, we recognize revenue progressively over time based on the extent of progress towards completion of the performance obligation. We recognize revenue based on a cost method as it best depicts the transfer of control to the customer which takes place as we incur costs. Revenues are recorded proportionally as costs are incurred.
We also manufacture certain components, assemblies, subsystems, and completed systems which service our RF and Specialty Components (RF&S Components) customers and certain aerospace and defense customers. We recognize revenue at a point in time upon transfer of control of the products to our customer. Point in time recognition was determined as our customers do not simultaneously receive or consume the benefits provided by our performance and the asset being manufactured has alternative uses to us.
Net sales consist of gross sales less an allowance for returns, which typically have been approximately 2% of gross sales. We provide our customers a limited right of return for defective PCBs including components, subsystems, and assemblies. We record an estimate for sales returns and allowances at the time of sale based on historical results and anticipated returns.
Cost of goods sold consists of materials, labor, outside services, and overhead expenses incurred in the manufacture and testing of our products. Shipping and handling fees and related freight costs and supplies associated with shipping products are also included as a component of cost of goods sold. Many factors affect our gross margin, including capacity utilization, product mix, production volume, supply chain issues, and yield.
Selling and marketing expenses consist primarily of salaries, labor related benefits, and commissions paid to our internal sales force, independent sales representatives, and our sales support staff, as well as costs associated with marketing materials and trade shows.
General and administrative costs primarily include the salaries for executive, finance, accounting, information technology, and human resources personnel, as well as expenses for accounting and legal assistance, incentive compensation expense, and gains or losses on the sale or disposal of property, plant, and equipment.
Research and development expenses consist primarily of salaries and labor related benefits paid to our research and development staff, as well as material costs.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Our consolidated condensed financial statements included in this Report have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosure of contingent assets and liabilities.
See Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in our Annual Report on Form 10-K for the fiscal year ended January 1, 2024 for further discussion of critical accounting policies and estimates. There were no material changes to our critical accounting policies and estimates since January 1, 2024.
21
RESULTS OF OPERATIONS
The relationship of various items to net sales in our consolidated condensed statements of operations was as follows:
|
|
Quarter Ended |
||||||||
|
|
April 1, 2024 |
|
April 3, 2023 |
||||||
Net sales |
|
|
100.0 |
|
% |
|
|
100.0 |
|
% |
Cost of goods sold |
|
|
81.8 |
|
|
|
|
84.2 |
|
|
Gross profit |
|
|
18.2 |
|
|
|
|
15.8 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
||
Selling and marketing |
|
|
3.5 |
|
|
|
|
3.9 |
|
|
General and administrative |
|
|
7.7 |
|
|
|
|
6.4 |
|
|
Research and development |
|
|
1.3 |
|
|
|
|
1.3 |
|
|
Amortization of definite-lived intangibles |
|
|
2.0 |
|
|
|
|
4.0 |
|
|
Restructuring charges |
|
|
0.7 |
|
|
|
|
0.8 |
|
|
Total operating expenses |
|
|
15.2 |
|
|
|
|
16.4 |
|
|
Operating income (loss) |
|
|
3.0 |
|
|
|
|
(0.6 |
) |
|
Other (expense) income: |
|
|
|
|
|
|
|
|
||
Interest expense |
|
|
(2.2 |
) |
|
|
|
(2.4 |
) |
|
Gain on sale of subsidiary |
|
|
— |
|
|
|
|
0.2 |
|
|
Other, net |
|
|
1.6 |
|
|
|
|
0.2 |
|
|
Total other expense, net |
|
|
(0.6 |
) |
|
|
|
(2.0 |
) |
|
Income (loss) before income taxes |
|
|
2.4 |
|
|
|
|
(2.6 |
) |
|
Income tax (provision) benefit |
|
|
(0.6 |
) |
|
|
|
1.5 |
|
|
Net income (loss) |
|
|
1.8 |
|
% |
|
|
(1.1 |
) |
% |
The following discussion and analysis is for the quarter ended April 1, 2024, compared to the same period ended April 3, 2023, unless otherwise stated.
Net Sales
Total net sales increased $25.7 million, or 4.7%, to $570.1 million for the first quarter of 2024 from $544.4 million for the first quarter of 2023. The increase in total net sales primarily resulted from an increase in net sales for the PCB reportable segment of $27.7 million, or 5.2%, to $561.8 million for the first quarter of 2024 from $534.1 million for the first quarter of 2023. The primary driver of this increase was demand growth in our aerospace and defense and data center computing end markets, partially offset by demand weakness in our medical, industrial, and instrumentation, automotive, and networking end markets, as well as the sale of our Shanghai backplane business in the first quarter of 2023, which had the effect of reducing $8.4 million of net sales when comparing the first quarter of 2024 to the first quarter of 2023. Net sales for the RF&S Components reportable segment decreased $2.0 million, or 19.9%, to $8.3 million for the first quarter of 2024 from $10.3 million for the first quarter of 2023, which was primarily due to lower demand in our networking end market.
Gross Margin
Overall gross margin increased to 18.2% for the first quarter of 2024 from 15.8% for the first quarter of 2023. Gross margin for the PCB reportable segment increased to 19.4% for the first quarter of 2024 from 16.5% for the first quarter of 2023. This increase was due to a more favorable product mix and improved execution in our North America region, partially offset by lower sales volume and less premium in some commercial markets. Gross margin for the RF&S Components reportable segment decreased to 47.5% for the first quarter of 2024 from 49.6% for the first quarter of 2023, primarily due to lower sales.
An important factor affecting gross margins is capacity utilization, which is measured by the actual production as a percentage of maximum capacity. This measure is particularly important in our high-volume PCB facilities in Asia, as a significant portion of our operating costs are fixed in nature. North America utilization figures are not as meaningful as Asia because bottlenecks in these high mix low volume facilities tend to occur in areas outside of plating, which is the core process that we use for calculating utilization rates. Capacity utilization for the first quarter of 2024 in our Asia and North America PCB facilities was 52% and 38%, respectively, compared to 52% and 39%, respectively, for the first quarter of 2023.
Selling and Marketing Expenses
Selling and marketing expenses decreased $1.0 million to $20.3 million, or 3.5% of net sales, for the first quarter of 2024 from $21.3 million, or 3.9% of net sales, for the first quarter of 2023. The decrease in selling and marketing expenses was primarily due to a decrease in commission expense.
22
General and Administrative Expenses
General and administrative expenses increased $8.6 million to $43.7 million, or 7.7% of net sales, for the first quarter of 2024 from $35.1 million, or 6.4% of net sales, for the first quarter of 2023. The increase in general and administrative expenses was primarily due to increases in certain personnel costs, stock-based compensation, bad debt, and other general and administrative spending.
Research and Development Expenses
Research and development expenses increased $0.2 million to $7.3 million, or 1.3% of net sales, for the first quarter of 2024 from $7.1 million, or 1.3% of net sales, for the first quarter of 2023. The increase in research and development expenses was primarily due to an increase in research and development projects, while the research and development expenses as a percentage of net sales was flat as a result of higher net sales offset by increased expenses.
Total Other Expense, Net
Total other expense, net decreased $7.3 million to $3.0 million for the first quarter of 2024 from $10.3 million for the first quarter of 2023, primarily due to an increase in foreign currency gains of $5.6 million resulting from the weakening Renminbi (RMB) in the first quarter of 2024 compared to the first quarter of 2023 and an increase in interest income of $1.7 million. We utilize the RMB at our China facilities for employee-related expenses, RMB denominated purchases, and other costs of running our operations in China.
Income Taxes
Income tax expense increased $11.5 million to $3.6 million for the first quarter of 2024 from an income tax benefit of $7.9 million for the first quarter of 2023. The increase in income tax expense was primarily due to an increase in pre-tax income.
Our effective tax rate is primarily impacted by the mix of foreign and U.S. income, tax rates in China and Hong Kong, the U.S. federal income tax rate, apportioned state income tax rates, the generation of credits and deductions available to us as well as changes in valuation allowances and certain non-deductible items. We had a net deferred income tax liability of approximately $44.2 million and $51.1 million as of April 1, 2024 and April 3, 2023, respectively.
Liquidity and Capital Resources
Our principal sources of liquidity have been cash provided by operations, the issuance of debt, and borrowings under our revolving credit facility. Our principal uses of cash have been to finance capital expenditures, finance acquisitions, fund working capital requirements, repay debt obligations, and repurchase common stock. We anticipate that financing capital expenditures, financing acquisitions, funding working capital requirements, servicing debt, and repurchasing common stock will be the principal demands on our cash in the future.
Cash flow provided by operating activities during the first quarter of 2024 was $43.9 million as compared to cash flow provided by operating activities of $55.1 million in the same period in 2023. The decrease in cash flow was primarily due to increased investment in working capital.
Net cash used in investing activities was approximately $42.6 million for the first quarter of 2024, primarily reflecting the use of $49.3 million for purchases of property, plant and equipment and other assets, partially offset by $6.7 million of proceeds from the sale of property associated with our Shanghai E-MS subsidiary. Net cash provided by investing activities was approximately $9.6 million for the first quarter of 2023, primarily reflecting $34.7 million of proceeds from the sale of property associated with our Shanghai E-MS subsidiary, $5.6 million of proceeds from the sale of a subsidiary, net of cash disposed, less $31.0 million for purchases of property, plant and equipment and other assets.
Net cash used in financing activities during the first quarter of 2024 was $11.1 million reflecting the use of $9.3 million for repurchases of common stock and $1.8 million for the repayment of long-term debt. Net cash used in financing activities during the first quarter of 2023 was $50.0 million for the repayment of long-term debt.
As of April 1, 2024, we had cash and cash equivalents of approximately $440.4 million, of which approximately $203.0 million was held by our foreign subsidiaries, primarily in China. Should we choose to remit cash to the United States from our foreign locations, we may incur tax obligations which would reduce the amount of cash ultimately available to the United States. However, we believe there would be no material tax consequences not previously accrued for the repatriation of this cash.
Our total 2024 capital expenditures are expected to be in the range of $170.0 million to $190.0 million.
23
Share Repurchases
On May 3, 2023, our Board of Directors authorized a share repurchase program (2023 Repurchase Program) allowing us to repurchase up to $100.0 million of our common stock from time to time through May 3, 2025. During the quarter ended April 1, 2024, we repurchased a total of 0.6 million shares of our common stock for $9.3 million (including commissions). As of April 1, 2024, the remaining amount in value available to be repurchased under the 2023 Repurchase Program was approximately $66.2 million.
Long-term Debt and Letters of Credit
As of April 1, 2024, we had $916.5 million of outstanding debt, net of discount and debt issuance costs, composed of $496.1 million of Senior Notes due March 2029, $340.4 million of Term Loan due May 2030 (Term Loan Facility), and $80.0 million under the Asia Asset-Based Lending Credit Agreement (Asia ABL).
Pursuant to the terms of the Senior Notes due March 2029 and Term Loan Facility, we are subject to certain affirmative and negative covenants, including limitations on indebtedness, corporate transactions, investments, dispositions, and restricted payments. Under the U.S. Asset-Based Lending Credit Agreement (U.S. ABL) and Asia ABL (collectively, the ABL Revolving Loans), we are also subject to various financial covenants, including leverage and fixed charge coverage ratios. As of April 1, 2024, we were in compliance with the covenants under the Senior Notes due March 2029, Term Loan Facility, and ABL Revolving Loans.
Based on our current level of operations, we believe that cash generated from operations, cash on hand, and cash from the issuance of term and revolving debt will be adequate to meet our currently anticipated capital expenditure, debt service, and working capital needs for the next 12 months. Additional information regarding our indebtedness, including information about the credit available under our debt facilities, interest rates, and other key terms of our outstanding indebtedness, is included in Part I, Item 1, Note 8, Long-term Debt and Letters of Credit, of the Notes to Consolidated Condensed Financial Statements included in this Quarterly Report on Form 10-Q.
Supplier Finance Program Obligations
We have agreements with financial institutions to facilitate payments to certain suppliers. Under the terms of the agreements, we confirm the validity of each supplier invoice to the respective financial institution upon receipt. The supplier receives payment from the financial institution, and we pay the financial institution based on the terms negotiated, which generally range from 160 days to 360 days. Liabilities associated with these agreements are recorded in accounts payable on the consolidated condensed balance sheets and amounted to $17.7 million and $18.8 million as of April 1, 2024 and January 1, 2024, respectively.
Contractual Obligations and Commitments
As part of our on-going operations, we enter into contractual arrangements that obligate us to make future cash payments. These obligations impact our liquidity and capital resource needs. Our estimated future obligations consist of long-term debt obligations, interest on debt obligations, derivative liabilities, purchase obligations, and leases. As of April 1, 2024, there were no material changes outside the ordinary course of business since January 1, 2024 to our contractual obligations and commitments and the related cash requirements.
Offset Agreements
We have and may continue to enter into industrial cooperation agreements, sometimes referred to as offset agreements, as a condition to obtaining orders for our products and services from customers in foreign countries. These agreements are intended to promote investment in the applicable country, and our obligations under these agreements may be satisfied through activities that do not require us to use cash, including transferring technology or providing manufacturing and other consulting support. The obligations under these agreements may also be satisfied through the use of cash for such activities as purchasing supplies from in-country vendors, setting up support centers, research and development investments, acquisitions, and building or leasing facilities for in-country operations. The amount of the offset requirement is determined by contract value awarded and negotiated percentages with customers. As of April 1, 2024, we had outstanding offset agreements of approximately $28.0 million, some of which extend through 2028. Offset programs usually extend over several years and in some cases provide for penalties in the event we fail to perform in accordance with contract requirements. To date, the Company has not been obligated to pay any such penalties.
Seasonality
We tend to experience modest seasonal softness in the first and third quarters due to holidays and vacation periods in China and North America, respectively, which limit production leading to stronger revenue levels in the second and fourth quarters.
Recently Issued Accounting Standards
For a description of recently adopted and issued accounting standards, including the respective dates of adoption and the expected effects on our results of operations and financial condition, see Part I, Item 1, Note 1, Nature of Operations and Basis of Presentation, of the Notes to Consolidated Condensed Financial Statements included in this Quarterly Report on Form 10-Q.
24
Item 3. Quantitative and Qualitative Disclosures About Market Risk
In the normal course of business operations, we are exposed to risks associated with fluctuations in interest rates, foreign currency exchange rates, and commodity prices. We address these risks through controlled risk management that includes the use of derivative financial instruments to economically hedge or reduce these exposures. We do not enter into derivative financial instruments for trading or speculative purposes.
We have not experienced any losses to date on any derivative financial instruments due to counterparty credit risk.
To ensure the adequacy and effectiveness of our foreign exchange and commodity price hedge positions, we continually monitor our foreign exchange forward positions and commodity hedge price positions, both on a stand-alone basis and in conjunction with their underlying foreign currency and commodity price exposures, from an accounting and economic perspective. However, given the inherent limitations of forecasting and the anticipatory nature of the exposures intended to be hedged, we cannot be assured that such programs will offset more than a portion of the adverse financial impact resulting from unfavorable movements in either foreign exchange rates or commodity prices. In addition, the timing of the accounting for recognition of gains and losses related to mark-to-market instruments for any given period may not coincide with the timing of gains and losses related to the underlying economic exposures and, therefore, may adversely affect our consolidated operating results and financial position.
Interest Rate Risks
Our business is exposed to risk resulting from fluctuations in interest rates. Our interest expense is more sensitive to fluctuations in the general level of Term Secured Overnight Financing Rate (SOFR) interest rates than to changes in rates in other markets. Increases in interest rates would increase interest expense relating to our outstanding variable rate borrowings and increase the cost of debt. Fluctuations in interest rates can also lead to significant fluctuations in the fair value of our debt obligations.
On March 23, 2023, we entered into a four-year pay-fixed, receive-floating (1-month Chicago Mercantile Exchange (CME) Term SOFR), interest rate swap arrangement with a notional amount of $250.0 million for the period beginning April 1, 2023 and ending on April 1, 2027. Under the terms of the interest rate swap, we pay a fixed rate of 3.49% against a portion of our Term SOFR-based debt and receive floating 1-month CME Term SOFR during the swap period.
At inception, we designated the interest rate swap as a cash flow hedge and the fair value of the interest rate swap was zero. As of April 1, 2024, the fair value of the interest rate swap was recorded as an asset in the amount of $5.7 million, of which $4.6 million is included as a component of prepaid expenses and other current assets and $1.1 million is included as a component of deposits and other non-current assets. As of January 1, 2024, the fair value of the interest rate swap was recorded as a net asset in the amount of $1.8 million, of which $3.3 million is included as a component of prepaid expenses and other current assets and $1.5 million is included as a component of other long-term liabilities. No ineffectiveness was recognized for the quarter ended April 1, 2024. During the quarter ended April 1, 2024, the interest rate swap decreased interest expense by $1.2 million.
See Liquidity and Capital Resources and Long-term Debt and Letters of Credit appearing in Part I, Item 2 of this Quarterly Report on Form 10-Q for further discussion of our financing facilities and capital structure. As of April 1, 2024, approximately 80.9% of our total debt was based on fixed rates. Based on our borrowings as of April 1, 2024, an assumed 100 basis point change in variable rates would cause our annual interest cost to change by $1.8 million.
Foreign Currency Exchange Rate Risks
In the normal course of business, we are exposed to risks associated with fluctuations in foreign currency exchange rates related to transactions that are denominated in currencies other than our functional currencies, as well as the effects of translating amounts denominated in a foreign currency to the U.S. Dollar as a normal part of our financial reporting process. Most of our foreign operations have the U.S. Dollar as their functional currency, however, one of our China facilities utilizes the Renminbi (RMB), which results in recognition of translation adjustments included as a component of other comprehensive income (loss). Our foreign exchange exposure results primarily from employee-related and other costs of running our operations in foreign countries, foreign currency denominated purchases, and translation of balance sheet accounts denominated in foreign currencies. We do not engage in hedging to manage this foreign currency risk, except for certain equipment purchases. However, we may consider the use of derivatives in the future. Our primary foreign exchange exposure is to the RMB. In general, our Chinese customers pay us in RMB, which partially mitigates this foreign currency exchange risk.
Our foreign subsidiaries may at times enter into forward exchange contracts to manage foreign currency risks in relation to certain purchases of equipment denominated in foreign currencies other than our functional currencies. The notional amount of the foreign exchange contracts was approximately $1.9 million (Euro (EUR) 1.8 million) as of April 1, 2024 and January 1, 2024.
25
Commodity Price Risks
We are exposed to certain commodity risks associated with prices for various raw materials, particularly copper, which may negatively affect our profitability. Copper clad laminates (CCLs), a key raw material for the manufacture of printed circuit boards (PCBs), are made from epoxy resin, glass cloth, and copper foil. We only buy a small amount of copper directly. However, copper is a major driver of laminate cost. We are hedging copper as a proxy for hedging laminate. As of April 1, 2024, we had commodity contracts with a notional quantity of (i) 600 metric tonnes for the period beginning April 1, 2024 and ending on June 30, 2024, (ii) 600 metric tonnes for the period beginning July 1, 2024 and ending on September 30, 2024, (iii) 500 metric tonnes for the period beginning October 1, 2024 and ending on December 31, 2024, and (iv) 500 metric tonnes for the period beginning January 1, 2025 and ending on March 31, 2025. As of April 1, 2024, the fair value of the commodity contracts was recorded as an asset in the amount of $0.5 million and included as a component of prepaid expenses and other current assets. As of January 1, 2024, the fair value of the commodity contracts was recorded as a liability in the amount of $0.3 million and included as a component of other current liabilities. We will continue to evaluate our commodity risks and may utilize commodity forward purchase contracts more in the future.
Debt Instruments
The fiscal calendar maturities of our debt instruments through 2028 and thereafter were as follows:
|
|
As of April 1, 2024 |
||||||||||||||||||||||||||||||||
|
|
Remaining 2024 |
|
|
2025 |
|
|
2026 |
|
|
2027 |
|
|
2028 |
|
|
Thereafter |
|
|
Total |
|
|
Fair Value |
|
|
Weighted |
||||||||
|
|
(In thousands) |
|
|
|
|||||||||||||||||||||||||||||
US$ Variable Rate (1) |
|
$ |
1,750 |
|
|
$ |
3,500 |
|
|
$ |
3,500 |
|
|
$ |
4,375 |
|
|
$ |
83,500 |
|
|
$ |
330,750 |
|
|
$ |
427,375 |
|
|
$ |
428,028 |
|
|
7.80% |
US$ Fixed Rate |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
500,000 |
|
|
|
500,000 |
|
|
|
450,285 |
|
|
4.00% |
Total |
|
$ |
1,750 |
|
|
$ |
3,500 |
|
|
$ |
3,500 |
|
|
$ |
4,375 |
|
|
$ |
83,500 |
|
|
$ |
830,750 |
|
|
$ |
927,375 |
|
|
$ |
878,313 |
|
|
|
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) under the Securities Exchange Act of 1934, as amended (Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our CEO and CFO have concluded that, as of April 1, 2024 such disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and (ii) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosures.
In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their desired control objectives, and our management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Changes in Internal Control over Financial Reporting
We continue to expand our implementation of an enterprise resource planning (ERP) system on a worldwide basis, which is expected to improve the efficiency of the financial reporting and related transaction processes. We are in the process of rolling out the ERP system to our remaining locations to standardize the ERP system.
There were no other changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended April 1, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
26
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, we may become a party to various legal proceedings arising in the ordinary course of our business. There can be no assurance that we will prevail in any such litigation. We believe that the amount of any reasonably possible or probable loss for known matters would not be material to our financial statements; however, the outcome of these actions is inherently difficult to predict. In the event of an adverse outcome, the ultimate potential loss could have a material adverse effect on our financial condition, results of operations, or cash flows in a particular period.
Item 1A. Risk Factors
There have been no material changes in our risk factors as previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended January 1, 2024.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The following table provides information about repurchases by us of shares of our common stock during the quarter ended April 1, 2024:
Period |
|
Total Number of Shares Purchased |
|
|
Average Price Paid per Share (1) |
|
|
Total Number of Shares Purchased As Part of Publicly Announced Program (2) |
|
|
Maximum Approximate Dollar of Shares that May Yet be Purchased Under the Program (3) |
|
||||
|
|
(In thousands, except per share data) |
|
|||||||||||||
January 2, 2024 - January 29, 2024 |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
75,568 |
|
January 30, 2024 - February 26, 2024 |
|
|
600 |
|
|
|
15.56 |
|
|
|
600 |
|
|
|
66,234 |
|
February 27, 2024 - April 1, 2024 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
66,234 |
|
Total for the quarter ended April 1, 2024 |
|
|
600 |
|
|
$ |
15.56 |
|
|
|
600 |
|
|
|
|
|
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the fiscal quarter ended April 1, 2024, none of the Company’s directors or executive officers
27
Item 6. Exhibits
Exhibit |
|
Exhibits |
|
|
|
31.1* |
|
CEO Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|
|
|
31.2* |
|
CFO Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|
|
|
32.1** |
|
CEO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|
|
|
32.2** |
|
CFO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|
|
|
101.INS |
|
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
|
|
|
101.SCH |
|
Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
|
|
|
104 |
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* Filed herewith.
** Furnished herewith. The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Commission and are not to be incorporated by reference into any filing of Registrant under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
28
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
TTM Technologies, Inc. |
|
|
|
|
|
/s/ Thomas T. Edman |
|
|
|
Dated: May 7, 2024 |
|
Thomas T. Edman |
|
|
President and Chief Executive Officer |
|
|
(Principal Executive Officer) |
|
|
|
|
|
/s/ Daniel L. Boehle |
|
|
|
Dated: May 7, 2024 |
|
Daniel L. Boehle |
|
|
Executive Vice President and Chief Financial Officer |
|
|
(Principal Financial Officer and Principal Accounting Officer) |
29